Consistently, immunoblots revealed that Cx43 levels were not different between endothelial cells treated with control/no EVs or EVs obtained from subjects at baseline, but they were decreased (by ~30%) in cells treated with ACS EVs (Figure 5B,C). Here, GJA1 is linked to acute chest syndrome.